American Journal of Neuroradiology 25:1715-1721, November-December 2004
© 2004 American Society of Neuroradiology
BRAIN
fMRI Biomarker of Early Neuronal Dysfunction in Presymptomatic Huntingtons Disease
a Department of Psychiatry, University of Iowa College of Medicine, Iowa City
b Department of Health Sciences, Carroll College, Waukesha, WI
c Department of Neurology, Medical College of Wisconsin, Milwaukee
d Psychology Assessment Center, Massachusetts General Hospital, Boston
BACKGROUND AND PURPOSE: Functional MR imaging (fMRI) has been used to probe basal ganglia function in people with presymptomatic Huntingtons disease (pre-HD). A previous fMRI study in healthy individuals demonstrated activation of the basal ganglia during a time-discrimination task. The current study was designed to examine the relative sensitivity of fMRI compared with that of behavioral testing and morphometric measurements in detecting early neurodegenerative changes related to Huntingtons disease (HD).
METHODS: Pre-HD participants were assigned to two groups based on estimated years to diagnosis of manifest disease: close <12 years and far
12 years. Age at disease onset was estimated using a regression equation based on the number of trinucleotide CAG repeats. The time-discrimination task required participants to determine whether a specified interval was shorter or longer than a standard interval of 1200 milliseconds.
RESULTS: Participants in the close group performed more poorly on the time-task discrimination than did control subjects; however, no differences were observed between far participants and control subjects. Similarly, close participants had reduced bilateral caudate volume relative to that of control subjects, whereas far participants did not. On functional imaging, close participants had significantly less activation in subcortical regions (caudate, thalamus) than control subjects; far participants had an intermediate degree of activation. In contrast, far participants had hyperactivation in medial hemispheric structures (anterior cingulate, pre-supplementary motor area) relative to close and control subjects.
CONCLUSION: Hyperactivation of medial prefrontal regions compensated for reduced subcortical participation during time discrimination in pre-HD. This pattern of brain activation may represent an early neurobiologic marker of neuronal dysfunction.
This article has been cited by other articles:
![]() |
G. Koch, M. Oliveri, and C. Caltagirone Neural networks engaged in milliseconds and seconds time processing: evidence from transcranial magnetic stimulation and patients with cortical or subcortical dysfunction Phil Trans R Soc B, July 12, 2009; 364(1525): 1907 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beste, C. Saft, O. Gunturkun, and M. Falkenstein Increased Cognitive Functioning in Symptomatic Huntington's Disease As Revealed by Behavioral and Event-Related Potential Indices of Auditory Sensory Memory and Attention J. Neurosci., November 5, 2008; 28(45): 11695 - 11702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Brandt, A. B. Inscore, J. Ward, B. Shpritz, A. Rosenblatt, R. L. Margolis, and C. A. Ross Neuropsychological Deficits in Huntington's Disease Gene Carriers and Correlates of Early "Conversion" J Neuropsychiatry Clin Neurosci, November 1, 2008; 20(4): 466 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Walker, B. R. Miller, J. N. Fritsch, S. J. Barton, and G. V. Rebec Altered Information Processing in the Prefrontal Cortex of Huntington's Disease Mouse Models J. Neurosci., September 3, 2008; 28(36): 8973 - 8982. [Abstract] [Full Text] [PDF] |
||||
![]() |
J S Paulsen, D R Langbehn, J C Stout, E Aylward, C A Ross, M Nance, M Guttman, S Johnson, M MacDonald, L J Beglinger, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 874 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Wolf, N. Vasic, C. Schonfeldt-Lecuona, G. B. Landwehrmeyer, and D. Ecker Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: evidence from event-related fMRI Brain, November 1, 2007; 130(11): 2845 - 2857. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Feigin, C. Tang, Y. Ma, P. Mattis, D. Zgaljardic, M. Guttman, J. S. Paulsen, V. Dhawan, and D. Eidelberg Thalamic metabolism and symptom onset in preclinical Huntington's disease Brain, November 1, 2007; 130(11): 2858 - 2867. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L Julien, J. C Thompson, S. Wild, P. Yardumian, J. S Snowden, G. Turner, and D. Craufurd Psychiatric disorders in preclinical Huntington's disease J. Neurol. Neurosurg. Psychiatry, September 1, 2007; 78(9): 939 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Johnson, J. C. Stout, A. C. Solomon, D. R. Langbehn, E. H. Aylward, C. B. Cruce, C. A. Ross, M. Nance, E. Kayson, E. Julian-Baros, et al. Beyond disgust: impaired recognition of negative emotions prior to diagnosis in Huntington's disease Brain, July 1, 2007; 130(7): 1732 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
D R Thiruvady, N Georgiou-Karistianis, G F Egan, S Ray, A Sritharan, M Farrow, A Churchyard, P Chua, J L Bradshaw, T-L Brawn, et al. Functional connectivity of the prefrontal cortex in Huntington's disease J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bobholz, S. M. Rao, L. Lobeck, C. Elsinger, A. Gleason, J. Kanz, S. Durgerian, and E. Maas fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume. Neurology, November 14, 2006; 67(9): 1640 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Blekher, S. A. Johnson, J. Marshall, K. White, S. Hui, M. Weaver, J. Gray, R. Yee, J. C. Stout, X. Beristain, et al. Saccades in presymptomatic and early stages of Huntington disease Neurology, August 8, 2006; 67(3): 394 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Finke, P. Bublak, M. Dose, H. J. Muller, and W. X. Schneider Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease Brain, May 1, 2006; 129(5): 1137 - 1151. [Abstract] [Full Text] [PDF] |
||||





